Direct Marketing Expenses definition

Direct Marketing Expenses has the meaning set forth in the Financial Definitions Exhibit.
Direct Marketing Expenses means the funds (which are part of the Budget) to facilitate the Detailing activities of Sales Representatives to Target Prescribers.
Direct Marketing Expenses means all internal costs (i.e. FTE Costs) and Out-of-Pocket Costs actually incurred by or on behalf of a Party [***]:

Examples of Direct Marketing Expenses in a sentence

  • The test is whether during any Operating Year the actual percentage of Casino Hotel gross revenues for either Salaries and Wages or Direct Marketing Expenses is more than 105% of the percentage of Casino Hotel gross revenues approved by the Owner in the Approved Budget for such Operating Year.


More Definitions of Direct Marketing Expenses

Direct Marketing Expenses shall have the meaning set forth in Schedule 1.5.
Direct Marketing Expenses means [*] Direct Marketing Expenses shall not include any Selling Expenses and the costs of activities that promote a Party’s business as a whole without being product specific (e.g., corporate image advertising).
Direct Marketing Expenses shall have the meaning set forth in Section 7.7.
Direct Marketing Expenses means the amount Invitrogen actually spent in support of Marketing Programs, provided, however, that for a given calendar year, such amount shall not exceed the Direct Marketing Budget for that calendar year.
Direct Marketing Expenses means the following costs incurred by the Parties or its Affiliates in the marketing and promotion of the Collaboration Product: (i) [ * ] , (ii) [ * ] , (iii) [ * ] and (iv) [ * ] or other study (including pharmacovigilence programs and outcome studies) that the JSC considers necessary or economically justifiable. For the avoidance of doubt, Direct Marketing Expenses shall [ * ] . “DMF” means (i) a Drug Master File filed with the FDA (and any foreign counterpart of a U.S. Drug Master File) and (ii) all supplements and amendments that may be filed with respect to thereto. “Drug Conjugation Materials” means the compounds monomethyl Auristatin E and monomethyl Auristatin F and certain variants, derivatives, analogues and salts thereof, as well as compounds that are useful in attaching such compounds to Antibodies, in each case to the extent included in or covered by the SGI Technology. Drug Conjugation Materials shall also include Improvements to Drug Conjugation Materials and any additional cytotoxic or cytostatic compounds that are included in New Technologies and that the Parties agree to include under this Agreement pursuant to Section 10.4.2. For the avoidance of doubt, Drug Conjugation Materials do not include ADC Product Candidates. “Drug Conjugation Technology” means chemical compositions and methods, including methods of manufacture, that are Controlled by SGI and that are useful to attach cytotoxins or cytostatic compounds to Antibodies, including the composition and methods of making and using cytotoxic or cytostatic compounds, as well as compositions and methods useful for attaching the foregoing cytotoxic or cytostatic compounds to Antibodies. “Effective Date” means the date set forth in the first line of this Agreement. “EMEA” means the European Medicines Agency and any successor agency(ies) thereto. “Events of Force Majeure” has the meaning set forth in Article 19. “Exclusive Antigen” means collectively, the First Exclusive Antigen, the Second Exclusive Antigen and the Third Exclusive Antigen, but specifically excluding any Collaboration Antigen. “Exclusive License” has the meaning set forth in Section 10.1.2. -9-
Direct Marketing Expenses means all reasonable out-of-pocket costs including, without limitation, costs of outsourcing any of the following functions incurred by the Parties, and all internal costs on an FTE basis at a mutually agreed upon FTE rate (to be determined prior to launch) for those individuals dedicated or allocated to such Product that are directly attributable to the following functions for the sale, promotion and marketing of a Product: [ * ]. Direct Marketing Expenses shall not include any Selling Expenses.
Direct Marketing Expenses means the following costs incurred by the Parties or its Affiliates in the marketing and promotion of the Collaboration Product: (i) [***], (ii) [***], (iii) [***] and (iv) [***] or other study (including pharmacovigilence programs and outcome studies) that the JSC considers necessary or economically justifiable. For the avoidance of doubt, Direct Marketing Expenses shall [***].